港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

869.902

-13.531-1.53%

漲家數：1

跌家數：12

平家數：- -

市盈率：- -

高：884.356

開：882.809

低：858.346

收：883.433

成交量：6,996.06萬

成交額：7.10億

市值：1,445.98億

流通市值：1,067.35億

資料載入中...

昊海生物科技(06826)9月8日斥資52.93萬港元回購3.15萬股

復星醫藥(600196.SH)子公司FXS5626片獲臨床試驗批准

復星醫藥：控股子公司藥品FXS5626獲臨床試驗批准

復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股

昊海生物科技(06826.HK)9月7日耗資約109.63萬港元回購6.55萬股

復星醫藥控股股東質押3.3億股還債累計質押比例超7成

復鋭醫療科技(01696)股價上升5.277%，現價港幣$1.995

阿斯达克财经

三生製藥(01530)出現大手買入47.45萬股，成交價$16.02，涉資760.149萬

阿斯达克财经

復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權套現2.94億美元

阿斯达克财经

港股異動 | 復星醫藥(02196.HK)早盤升逾5% 控股子公司279.96億印度盧比出售Gland Pharma約6.00%股權

港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)

復星醫藥(02196.HK)擬回購不超過10億港元H股

復星醫藥：擬12個月內回購不超過10億港元H股

南方财经网

復星醫藥(600196.SH)控股子公司擬出售Gland Pharma部分股權

復鋭醫療科技(01696.HK)將於9月11日派發末期股息每股0.095港元

復星醫藥(02196.HK)獲控股股東復星高科技質押3.3億股A股

復星醫藥：復星高科技質押3.30億股用於償還債務

南方财经网

港股異動 | 時代天使(06699.HK)漲近5% 上半年海外業務實現扭虧為盈大摩看好公司海內外市場具強勁銷量動能

港股異動 | 時代天使(06699)漲近5% 上半年海外業務實現扭虧為盈大摩看好公司海內外市場具強勁銷量動能

智通财经网

港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BK1593/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":869.9022,"timestamp":1789114133774,"preClose":883.43335,"halted":0,"volume":69960617,"delay":0,"changeRate":-0.015317,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-13.531128,"latestTime":"09-11 16:00:00","open":882.80945,"high":884.35583,"low":858.3457,"amount":709509713,"amplitude":0.029442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.117247,"peRate":10.209827,"turnoverRate":0.003127,"increases":1,"decrements":12,"flats":0,"marketCap":144597722624,"floatMarketCap":106735221760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":884.35583,"amplitude":0.029442,"preClose":883.43335,"low":858.3457,"pbRate":"1.117247","latestPrice":869.9022,"volume":69960617,"delay":0,"open":882.80945,"prevYearClose":1094.978,"prevWeekClose":913.749,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":913.749,"twentyDayClose":957.712,"sixtyDayClose":841.957,"secType":"PLATE","market":"HK","turnoverRate":0.003127,"peRate":10.209827,"marketCap":144597722624,"floatMarketCap":106735221760,"timestamp":1789114133774,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":1,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665507329","title":"昊海生物科技(06826)9月8日斥資52.93萬港元回購3.15萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665507329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665507329?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:43","pubTimestamp":1788860639,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年9月8日斥资52.93万港元回购3.15万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665132698","title":"復星醫藥(600196.SH)子公司FXS5626片獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665132698","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665132698?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:13","pubTimestamp":1788858794,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，近日，公司控股子公司上海复星医药产业发展有限公司收到国家药品监督管理局关于同意FXS5626片用于治疗非节段型白癜风开展II/III期适应性无缝设计临床试验的批准。复星医药产业拟于条件具备后于中国境内开展该药品的相关临床研究。截至2026年8月，公司现阶段针对FXS5626的累计研发投入约为1.08亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK0028","BK0096","BK0196","BK0012","BK0187","BK0183","BK0060","BK0188","600196","BMED","BK0175","02196","IBBQ","BK1191","MDTX","BK1515","PSYK","BK0239","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732638","title":"復星醫藥：控股子公司藥品FXS5626獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732638","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:59","pubTimestamp":1788857986,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02196","BK0028","BK0012","600196","BK1191","BK0196","BK0096","BK1515","BK0175","BK0188","BK0239","BK0060","BK0187","BK0183","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315565","title":"復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315565","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315565?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月7日，该公司斥资117.52万港元回购7万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02196","BK0028","BK0012","600196","BK1191","BK0196","BK0096","BK1515","BK0175","BK0188","BK0239","BK0060","BK0187","BK0183","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631893","title":"昊海生物科技(06826.HK)9月7日耗資約109.63萬港元回購6.55萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:51","pubTimestamp":1788771106,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392895","title":"復星醫藥控股股東質押3.3億股還債 累計質押比例超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392895","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392895?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:37","pubTimestamp":1788763023,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 复星医药 9月5日披露的关于股东部分股份质押的公告显示，公司于2026年9月4日接到控股股东上海复星高科技(集团)有限公司的通知，其已将所持有的公司部分A股股份办理质押手续。　　复星高科技本次质押股份数量为3.3亿股，占其所持股份数比例的34.32%，占公司股份总数比例为12.36%。质押起始日为2026年9月3日，质押到期日为2028年9月8日。　　控股股东复星高科技质押公司股份均系用于融资。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["600196","02196","BK0239","BK1191","BK0175","BK0188","BK0096","BK1515","BK0183","BK1593","BK0012","BK0060","BK0028","BK0187","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215394","title":"復鋭醫療科技(01696)股價上升5.277%，現價港幣$1.995","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215394","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215394?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:20","pubTimestamp":1788762000,"startTime":"0","endTime":"0","summary":"[上升股]复锐医疗科技(01696) 股价在下午02:19比前收市价上升5.277%，现股价为港币$1.995。至目前为止，今日最高价为$1.995，而最低价为$1.925。总成交量为6.76万股，总成交金额为港币$13.255万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609073415/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609073415/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1585","BK1100","BK1593","01696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665966603","title":"三生製藥(01530)出現大手買入47.45萬股，成交價$16.02，涉資760.149萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665966603","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665966603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:14","pubTimestamp":1788750840,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在上午11:14出现大手买入，成交量为47.45万，成交价为港币$16.02，涉资760.149万。至目前为止，股价跌1.416%，今日最高价为$16.22，而最低价为$15.81，总成交量为529.133万股，总成交金额港币$8.464千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074476/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074476/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","HK0000165453.HKD","BK1583","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839583","title":"復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權  套現2.94億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839583","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:03","pubTimestamp":1788746580,"startTime":"0","endTime":"0","summary":"复星国际公布，附属复星医药全资附属复星医药新加坡公司，通过大宗交易及集中竞价方式出售共计989.7万股Gland Pharma Limited股份，约占该公司股份总数的6%，出售事项的总代价约为279.96亿卢比。Gland Pharma Limited是一间根据印度法律成立的公司，其主要从事注射剂药品的生产制造业务，其股份于孟买证券交易所及印度国家证券交易所上市，股份代号：GLAND。于出售事项前及完成后，复星国际分别持有Gland Pharma约51.76%及45.76%的股权，该公司仍为复星医药及复星国际的附属。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600196","BK0096","BK0175","BK0187","BK0239","BK1515","BK0196","BK0183","BK0188","BK0028","BK0060","BK1593","02196","BK0012","BK1230","MNDmain","BK1191","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935403","title":"港股異動 | 復星醫藥(02196.HK)早盤升逾5% 控股子公司279.96億印度盧比出售Gland Pharma約6.00%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935403","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935403?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:35","pubTimestamp":1788744909,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1191","BK1515","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665836774","title":"港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665836774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665836774?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 06:53","pubTimestamp":1788735233,"startTime":"0","endTime":"0","summary":"西湖大学生命科学学院教授黄晶表示，AI辅助新药研发已不止于概念，而真正可以支撑原创药物从发现走向临床，直至上市。艾普司韦是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。中国AI制药市场规模2025年已突破6亿元。从经营数据来看，AI相关业务正成为部分企业订单和收入增长的重要驱动力；与此同时，下游药企也在积极拥抱AI，研发提效成果逐步显现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","IBBQ","ARTY","BK4588","03696","06978","BK1593","AGIX","BK1141","AIPO","02228","QTOC","BK1191","159992","MEDX","VXUS","BK4585","BK1161","CHAT","LNGR","BK1515","02196","KCAI","VTHR","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665517364","title":"復星醫藥(02196.HK)擬回購不超過10億港元H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665517364","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665517364?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:25","pubTimestamp":1788690331,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","02196","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364975","title":"復星醫藥：擬12個月內回購不超過10億港元H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364975","media":"南方财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364975?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:12","pubTimestamp":1788689520,"startTime":"0","endTime":"0","summary":"南财智讯9月6日电，复星医药（02196.HK）发布自愿公告，基于对集团发展前景的信心及内在价值的认可，经董事会批准，公司拟自2026年8月27日起12个月内回购H股，回购资金总额不超过10亿港元。本次回购依据2026年6月16日股东周年大会、H股类别股东会及A股类别股东会授予董事会的H股回购一般性授权实施。回购H股用途包括注销或作为库存股份持有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609063866106963.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609063866106963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK0175","BK0096","BK0187","BK0028","BK0188","BK0196","BK0239","BK0060","BK0183","BK0012","600196","BK1515","02196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361715","title":"復星醫藥(600196.SH)控股子公司擬出售Gland Pharma部分股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361715","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361715?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 17:00","pubTimestamp":1788685207,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 发布公告，印度时间2026年9月4日，公司控股子公司复星医药新加坡公司通过大宗交易及集中竞价方式出售共计989.70万股 Gland Pharma 股份，交易总对价为279.96亿印度卢比，均价约为2,828.78印度卢比/股、较前一交易日收盘价格折让约2.72%。紧随本次交易完成后，集团仍持有 Gland Pharma 约45.76%的股权、为其控股股东，Gland Pharma 仍为集团合并报表范围内子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600196","02196","BK0239","BK1191","BK0175","BK0188","BK0096","BK1515","BK0183","BK1593","BK0012","BK0060","BK0028","BK0187","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664331818","title":"復鋭醫療科技(01696.HK)將於9月11日派發末期股息每股0.095港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664331818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664331818?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:56","pubTimestamp":1788522961,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","BK1100","01696","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338732","title":"復星醫藥(02196.HK)獲控股股東復星高科技質押3.3億股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664338732?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 17:26","pubTimestamp":1788513984,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03130","BK1191","BK1593","BK1147","02846","07233","BK1515","83188","82846","02827","02196","03188","83130"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664840380","title":"復星醫藥：復星高科技質押3.30億股用於償還債務","url":"https://stock-news.laohu8.com/highlight/detail?id=2664840380","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664840380?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:25","pubTimestamp":1788510357,"startTime":"0","endTime":"0","summary":"南财智讯9月4日电，复星医药公告，公司控股股东上海复星高科技(集团)有限公司于2026年9月3日将其持有的330000000股A股股份办理质押，占其所持股份比例34.32%，占公司总股本比例12.36%，质押用途为偿还债务。本次质押后，复星高科技累计质押股份数量为696275000股，占公司总股本26.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609043865437383.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609043865437383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK0187","BK0096","BK0060","BK1593","BK0239","BK0183","BK0188","BK0012","BK0196","BK0028","02196","BK1515","600196","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664384349","title":"港股異動 | 時代天使(06699.HK)漲近5% 上半年海外業務實現扭虧為盈 大摩看好公司海內外市場具強勁銷量動能","url":"https://stock-news.laohu8.com/highlight/detail?id=2664384349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664384349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:19","pubTimestamp":1788502744,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06699","BK1587","BK1583","BK1100","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664384342","title":"港股異動 | 時代天使(06699)漲近5% 上半年海外業務實現扭虧為盈 大摩看好公司海內外市場具強勁銷量動能","url":"https://stock-news.laohu8.com/highlight/detail?id=2664384342","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664384342?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:19","pubTimestamp":1788502744,"startTime":"0","endTime":"0","summary":"时代天使(06699)涨近5%，截至发稿，涨3.62%，报98.7港元，成交额6062.76万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260904/20260904142443_92018.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260904/20260904142443_92018.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0795875169.SGD","LU2487616109.SGD","LU1064131342.USD","LU0390134368.USD","LU1720051108.HKD","LU0210528500.USD","LU2089284900.SGD","LU0267386448.USD","LU0098860793.USD","BK4534","LU2357305700.SGD","BK1593","LU0912757837.SGD","LU1988902786.USD","BK4588","LU0225283273.USD","LU1162221912.USD","LU1548497426.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU0971096721.USD","BK1583","IE00BZ1G4Q59.USD","LU0053666078.USD","LU0006306889.USD","KBWB","LU0528227936.USD","LU2089283258.USD","VXUS","BK4504","06699","BK4516","BK4585","IAI","LU1720051017.SGD","LU2028103732.USD","BK4127","LU2264538146.SGD","LU2133065610.SGD","LU2111349929.HKD","LU1363072403.SGD","LU0882574139.USD","LU0795875086.SGD","IE00B775SV38.USD","BK1587","BK4581","LU0234570918.USD","LU1791710582.SGD","LU1074936037.SGD","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386607","title":"港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386607","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386607?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 11:52","pubTimestamp":1788493955,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，四环医药午前涨近4%，截至发稿，涨3.92%，报0.795港元，成交额981.3万港元。Innobic(亚洲)将作为经销商，负责目标产品于目标区域的药品注册、本地市场营销及商业化运营。轩竹生物将按约定供货价格供应目标产品，以支持目标产品在目标区域的商业化活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","BK1515","KCAI","BK1593","BK1191","VXUS","02575","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":67,"code":"91000000","status":"200"}]}}